Ignite Creation Date:
2024-07-17 @ 10:46 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06498921
Status:
COMPLETED
Last Update Posted:
2024-07-12
First Post:
2024-07-05
Brief Title:
An Observational Study to Learn More About the Use of Darolutamide as a Part of a Combination Therapy in Belgian Men With Metastatic Hormone-Sensitive Prostate Cancer in Routine Medical Care
Sponsor:
Bayer
Organization:
Bayer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-09-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-09-15
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-05
First Submit QC Date:
None
Study First Post Date:
2024-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL